MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0045568
Cytocare Formulations Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.44 Cr
▲ 39% YoY
Net profit · FY 2025
₹1.59 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹10.87 Lakh
EBITDA margin 7.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹20 Lakh
No open charges
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
About Cytocare Formulations Private Limited
Data last updated:
Cytocare Formulations Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 July 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB2007PTC117462. Its GSTIN is 19AADCC6548D1ZN (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gopa Ghosh and Partha Pratim Ghosh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat: B 1st Floor 70C Sadananda Road, Kolkata, West Bengal, India – 700026.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.44 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹1.59 Lakh (net margin 1.1%) and EBITDA of ₹10.87 Lakh (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
As per MCA filings, the company has satisfied charges of ₹20 Lakh on record.
Cytocare Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0045568). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cytocare.in.
Company details
CIN U24232WB2007PTC117462
Registration Number 117462
Incorporation Date 25 July 2007
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0045568
Key People
Gopa Ghosh Director Partha Pratim Ghosh Director Recognitions & Rankings of Cytocare Formulations
Contact details
Cytocare Formulations Private Limited's registered office is in Kolkata, West Bengal. Its website is cytocare.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat: B 1st Floor 70C Sadananda Road, Kolkata, West Bengal, India – 700026
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cytocare Formulations Private Limited, buy the company report.
Comprehensive company report
Cytocare Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cytocare Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cytocare Formulations Private Limited, buy the company report.
Financials of Cytocare Formulations Private Limited
FY 2025 filings availableCytocare Formulations Private Limited reported revenue of ₹1.44 Cr (up 39% YoY) for FY 2025.
Revenue · FY 2025
₹1.44 Cr ▲ 39%
Net profit · FY 2025
₹1.59 Lakh margin 1.1%
EBITDA · FY 2025
₹10.87 Lakh margin 7.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▼ 39%
3 years · compounded
▲ 4%
5 years · compounded
▼ 8%
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 39% growth in the latest year. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cytocare Formulations Private Limited, buy the company report.
Board of directors of Cytocare Formulations Private Limited
Cytocare Formulations has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gopa Ghosh | Director | 25 Jul 2007 | 19 Years 3 Months | Current |
| Partha Pratim Ghosh | Director | 25 Jul 2007 | 19 Years 3 Months | Current |
Peer comparison
Cytocare Formulations Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sharma Drugs Private Limited | ₹1.44 Cr (FY 2025) | -6.0% | New Delhi, Delhi, India | |||
| Atrol Pharmaceuticals Private Limited | ₹1.44 Cr (FY 2025) | 935.0% | Bangalore, Karnataka, India | |||
| Cytocare Formulations Private Limitedthis company | ₹1.44 Cr (FY 2025) | ₹1.59 Lakh | 1.1% | 39.0% | Kolkata, West Bengal, India | |
| Solar Healthcare Private Limited | ₹1.44 Cr (FY 2025) | -9.0% | Delhi, India | |||
| Valtechnik India Private Limited | ₹1.44 Cr (FY 2025) | -24.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Cytocare Formulations Private Limited, buy the company report.
Auditor
Cytocare Formulations Private Limited is audited by SATISH CHOUDHARY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SATISH CHOUDHARY | FY 2023 | 314505 |
Shareholding
The shareholding of Cytocare Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cytocare Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹20 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Feb 2012 | 10345923 | Vijaya Bank | ₹20 Lakh | Satisfied |
To see the full charge records of Cytocare Formulations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cytocare Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cytocare Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cytocare Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AADCC6548D1ZN | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cytocare Formulations Private Limited, buy the company report.
Recent activity
Cytocare Formulations Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Gopa Ghosh was appointed as Director on 25 Jul 2007.
AGM
Cytocare Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cytocare Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Charges
A charge registered on 15 Feb 2012 via Charge ID 10345923 with Vijaya Bank was fully satisfied on 29 Jul 2017.
Charges
A charge with Vijaya Bank amounted to Rs. 20.00 Lakh with Charge ID 10345923 was registered on 15 Feb 2012.
Appointed
Gopa Ghosh was appointed as Director.
Appointed
Partha Pratim Ghosh was appointed as Director.
Incorporation
25 Jul 2007
Cytocare Formulations Private Limited was registered on 25 Jul 2007 with Roc Kolkata I & aged 19 years 3 months as per MCA records.
Frequently asked questions
Cytocare Formulations is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 July 2007 (19+ years old) and is registered under CIN U24232WB2007PTC117462.
Cytocare Formulations has 2 current directors:
- Gopa Ghosh - Director
- Partha Pratim Ghosh - Director
The latest financial statements of Cytocare Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cytocare Formulations is 19AADCC6548D1ZN, registered in West Bengal.
The CIN (Corporate Identification Number) of Cytocare Formulations is U24232WB2007PTC117462. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cytocare Formulations was incorporated on 25 July 2007, making it 19+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Cytocare Formulations by revenue are Sharma Drugs Private Limited, Atrol Pharmaceuticals Private Limited, Solar Healthcare Private Limited, Valtechnik India Private Limited, all in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Gopa Ghosh was appointed as Director on 25 Jul 2007. Partha Pratim Ghosh was appointed as Director on 25 Jul 2007.
Yes, Cytocare Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0045568).
Cytocare Formulations can be reached through the website cytocare.in. Its registered office is in Kolkata, West Bengal, India.
The registered office of Cytocare Formulations is at Flat: B 1st Floor 70C Sadananda Road, Kolkata, West Bengal, India – 700026.